To date, the number of reported cases of both syndromes, HSAN-VIII and MiTES harboring PRDM12 mutations has expanded, and it is likely to increase further in the future due to the advancement of sequencing strategies [53,54,55,56,57,58,59,60]. Here, PRDM12 is linked to hereditary sensory and autonomic neuropathy.